Viewing Study NCT06348134


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2026-03-06 @ 2:04 PM
Study NCT ID: NCT06348134
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-03
First Post: 2024-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
Sponsor: University of Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Human Epidermal Growth Factor 2 Negative Carcinoma of Breast View
None HER2-positive Breast Cancer View
None Breast Cancer View
Keywords: